Clinical Trial Update: The Effects of SGLTi on Diabetic Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the effects of SGLT inhibitors on diabetic cardiomyopathy in patients with type 2 diabetes and heart failure with reduced eje…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Hong Kong | Conditions: Type2 Diabetes, Heart Failure With Reduced Ejection Fraction | Phase 4 | Status: UNKNOWN